Remove Ablation Remove Electrophysiology Remove Stenosis
article thumbnail

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

DAIC

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The

Ablation 111
article thumbnail

Retrograde coronary venous ethanol ablation for ventricular tachycardia in a patient with inaccessible substrate due to previous surgery

Journal of Cardiovascular Electrophysiology

Abstract Introduction Catheter-based radiofrequency (RF) ablation is generally regarded as the standard approach for patients with ventricular tachycardia (VT) refractory to antiarrhythmic drug therapy and may be considered as a first-line approach when there is a preference to avoid these agents.

article thumbnail

Comparison of pulsed?field ablation versus very high power short duration?ablation for pulmonary vein isolation

Journal of Cardiovascular Electrophysiology

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. One clinically nonsignificant PV stenosis occurred in the VHPSD group. Data comparing PFA to VHPSD-PVI is lacking.

article thumbnail

“Diastolic blind spots” in VT

Dr. S. Venkatesan MD

The term, VT mapping has been in vogue in clinical electrophysiology for more than half a century, right from Dr.Josephson and Wellens’ days. While , treating VTs with drugs is still a choice, permanent solutions by defining the VT circuit and ablating them, is the new norm. How can we remember this EP lesson easily ?

article thumbnail

Stent‐in‐Stent Intervention for Pulmonary Vein in Stent Restenosis: A Long‐Term Follow‐Up Case Report

Journal of Cardiovascular Electrophysiology

Method and Results A 54-year-old man with long history of atrial fibrillations developed PVS secondary to multiple radiofrequency ablation procedures. The stenosis was treated with a stent. Balloon angioplasty seems to be the widely preferred treatment of choice. He has since remained asymptomatic over 3 years of follow-up.

Stent 40
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

Session 104) - What Is Really New in Electrophysiology That Will Change My Practice? The Guidelines Sessions at ACC.24 24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

article thumbnail

Different leadless pacemakers working in harmony (Aveir in the atrium/Micra AV2 in the ventricle) in a patient with dextrocardia and double outlet right ventricle after high?risk infected device extraction

Journal of Cardiovascular Electrophysiology

Results A 27-year-old male with dextrocardia with double outlet right ventricle, subaortic ventricular septal defect, and pulmonary stenosis status-post pulmonary valve replacement complicated by ventricular pacing dependence and subsequent atrial pacing dependence after atriotomy-based atypical flutter ablation developed recurrent mediastinitis and (..)